Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Moreau P, Touzeau C. Multiple myeloma: from front-line to relapsed therapies. Am Soc Clin Oncol Educ Book. 2015;35:e504–11.
2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines®). Multiple myeloma (version 2.2016). 2015. http://www.nccn.org . Accessed 16 Dec 2015.
3. Kumar S. Implications of oral proteasome inhibition: impact on patients [abstract no. PS-029]. Clin Lymphoma Myeloma Leuk. 2015;15(Suppl 3):e14–5.
4. Millennium Pharmaceuticals. Velcade® (bortezomib): prescribing information. 2015. http://www.velcade.com/ . Accessed 16 Dec 2015.
5. Onyx Pharmaceuticals. Kyprolis® (carfilzomib): prescribing information. 2015. http://www.kyprolis.com/ . Accessed 16 Dec 2015.
Cited by
115 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献